Doctors unite to map safer path for Acne's most powerful drug
NCT ID NCT07296523
Summary
This study aims to create clearer and safer guidelines for doctors prescribing isotretinoin, a very effective but strong acne medication. A panel of 15 experienced dermatologists will share their expert opinions to agree on best practices for dosing, monitoring, and safety. The goal is to reduce confusion and improve patient care by establishing consistent recommendations for this important treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACNE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Venus Research Center
Cairo, Egypt
Conditions
Explore the condition pages connected to this study.